Enoxaparin Shows Safety in Angioplasty – STEEPLE Study

Enoxaparin Shows Safety in Angioplasty – STEEPLE Study

0:00

Gilles Montalescot The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the find

Gilles Montalescot

Gilles Montalescot

The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin.Gilles Montalescotpresented the findings in Stockholm and talked about them with Audio Medica.

Click here for all the interviews from ESC 2005

Related Episodes

Bivalirudin For Angioplasty: Expensive Heparin?

Bivalirudin For Angioplasty: Expensive Heparin?

Tony Gershlick Tony Gershlick, University of Leicester Adnan Kastrati, Deutsches Herzzentrum, Munich Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing deat

Audio Journal of Oncology Volume 16 Number 8

Audio Journal of Oncology Volume 16 Number 8

Scientific Editors: George Canellos, Pat Price, Gordon McVie, Gianni Bonadonna In this edition: Bevacizumab and Survival in Metastatic Breast Cancer Source: N Engl J Med 357:26 George Canellos, Dana-F

Remove Thrombus Before Primary Angioplasty!

Remove Thrombus Before Primary Angioplasty!

Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,